Ironstone Properties (IRNS) 10-Q 17 May 22 2022 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2022	May 15, 2022
Document Information [Line Items]
Entity Central Index Key	0000723269
Entity Registrant Name	IRONSTONE PROPERTIES, INC.
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	0-12346
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	95-2829956
Entity Address, Address Line One	909 Montgomery Street
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94133
City Area Code	415
Local Phone Number	551-8600
Title of 12(g) Security	Common Stock, $0.01 par value
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		2,191,689

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
ASSETS:
Cash	$ 8,655	$ 30,717
Investments:
Marketable securities	511,888	604,318
Non-marketable securities	4,960,344	4,960,344
Total assets	5,480,887	5,595,379
LIABILITIES AND STOCKHOLDERS' EQUITY:
Accounts payable and accrued expenses	27,857	34,202
Line of credit borrowings	348,843	348,843
Interest payable line of credit	1,259	1,259
Note payable	2,386,950	2,329,510
Note payable - related party	624,313	624,313
Interest payable - related party	193,643	181,905
Deferred income tax payable	318,306	318,306
Total liabilities	3,901,171	3,838,338
Stockholders' equity
Preferred stock, $0.01 par value, 5,000,000 shares authorized, no shares issued and outstanding	0	0
Common stock, $0.01 par value, 25,000,000 shares authorized, of which 2,937,225 shares are issued and outstanding as of March 31, 2022 and December 31, 2021	29,372	29,372
Additional paid-in capital	21,839,083	21,839,083
Additional paid-in capital - stock options	273,363	212,506
Accumulated deficit	(21,564,277)	(22,498,875)
Accumulated other comprehensive Income	1,524,748	2,697,529
Stockholders' Equity before Treasury Stock	2,102,289	2,279,615
Less: Treasury Stock, 745,536 shares, at cost	(522,574)	(522,574)
Total stockholders' equity	1,579,715	1,757,041
Total liabilities and stockholders' equity	$ 5,480,887	$ 5,595,379

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - $ / shares	Mar. 31, 2022	Dec. 31, 2021
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	25,000,000	25,000,000
Common stock, shares issued (in shares)	2,937,225	2,937,225
Common stock, shares outstanding (in shares)	2,937,225	2,937,225
Treasury stock, shares (in shares)	745,536	745,536

Condensed Consolidated Statemen

Condensed Consolidated Statements of Comprehensive Profit (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Compensation - stock options	$ 60,857	$ 0
Professional fees	6,719	2,608
General and administrative expenses	2,925	(39)
State and local taxes	(592)	7,349
Total operating expenses	69,909	9,918
Loss from operations	(69,909)	(9,918)
Other expense:
Interest expense	(64,106)	(61,637)
Interest expense to related party	(11,737)	(7,842)
Net operating loss	(145,752)	(79,398)
COMPREHENSIVE PROFIT (LOSS), NET OF TAX:
Net operating loss	(145,752)	(79,398)
Unrealized holding loss arising during the period	(92,430)	0
Deferred income tax	0	0
Comprehensive profit (loss) after income taxes	$ (238,182)	$ (79,398)
Basic gain (loss) per share
Net operating loss per share (in dollars per share)	$ (0.07)	$ (0.04)
Net comprehensive profit per share (in dollars per share)	$ (0.11)	$ (0.04)
Shares outstanding (in shares)	2,191,689	2,191,689

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net lncome (loss)	$ (145,752)	$ (79,398)
Changes in operating assets and liabilities:
Accounts payable and accrued expenses	(6,344)	5,858
Interest payable	57,440	54,949
Interest payable - related party	11,737	7,842
Net cash used in operating activities	(82,919)	(10,749)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of notes payable	0	306,688
Paid in capital stock options	60,857	0
Prior period adjustment accrued expenses	0	0
Net cash provided by financing activities	60,857	306,688
CASH FLOWS FROM INVESTING ACTIVITIES:
Investment in non-marketable securities	0	(178,824)
Net cash provided (used) by financing activities	0	(178,824)
Net increase (decrease) in cash	(22,062)	117,115
Cash at beginning of period	30,717	(39)
Cash at end of period	8,655	117,076
Supplemental disclosure of cash flow information:
Cash paid during the period for state franchise taxes	1,095	0
Cash paid during the period for interest	6,666	6,843
Share-Based Payment Arrangement, Option [Member] | Equity Incentive Plan [Member]
Supplemental noncash investing and financing activities:
Officer and director common stock options issued	$ 60,857	$ 0

Note 1 - Business and Summary o

Note 1 - Business and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2022
Notes to Financial Statements
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]	1. Business Activities Ironstone Group, Inc. and subsidiaries have no 1972. Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of Ironstone Group, Inc. and its subsidiaries, AcadiEnergy, Inc., Belt Perry Associates, Inc., DeMoss Corporation, and TaxNet, Inc. (collectively the “Company”). All significant intercompany accounts and transactions have been eliminated in consolidation. Basis of Presentation The unaudited condensed consolidated financial statements included herein have been prepared by the Company in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures, normally included in financial statements prepared in accordance with U.S. GAAP, have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, these unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary to present fairly the financial position of the Company as of March 31, 2022 December 31, 2021, three March 31, 2022 March 31, 2021 three March 31, 2022 March 31, 2021. not may not not There have been no 10 December 31, 2021. Going Concern These financial statements contemplate the realization of assets and the satisfaction of liabilities in the normal course of business. Ironstone Group has incurred losses and negative cash flows from operations over the last ten not Marketable and Non-Marketable Securities Marketable and non-marketable securities have been classified by management as available for sale in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 320, March 31, 2022 December 31, 2021 not not Securities determined to be non-marketable by the Company do not that it deems most relevant. Among the factors considered by the Company in determining the fair value of financial instruments are discounted anticipated cash flows, the cost, terms and liquidity of the instrument, the financial condition, operating results and credit ratings of the issuer or underlying company, the quoted market price of publicly traded securities with similar duration and yield, the Black-Scholes Options Valuation methodology adjusted for active market, the share price of recent round of financings by an outsider, and other considerations on a case-by-case basis and other factors generally pertinent to the valuation of financial instruments. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates made in the financial statements relate to the valuation of the Company’s non-marketable investments. Actual results could differ from those estimates. Income Taxes Ironstone follows the authoritative guidance on accounting for and disclosure of uncertainty in tax positions, which requires the Company to determine whether a tax position of Ironstone is more likely than not not 50% no The Company files tax returns as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examination by federal, state, local, and foreign jurisdictions, where applicable. As of March 31, 2022, 2018 2017 Stock-Based Compensation Ironstone recognizes the fair value of stock options granted on a straight-line basis over the requisite service period of the option grant, which is the standard vesting term of three The full impact of stock-based compensation in the future is dependent upon, among other things, the total number of stock options granted, the fair value of the stock options at the time of grant and the tax benefit that Ironstone may may not as assumptions regarding a number of highly complex and subjective variables. These variables include but are not Basic and Diluted Loss per Share Basic loss per share (“EPS”) excludes dilution and is computed by dividing net income (loss) applicable to common shareholders by the weighted average number of common shares actually outstanding during the period. Diluted EPS reflects the dilution from potentially dilutive securities, except where inclusion of such potentially dilutive securities would have an anti-dilutive effect, using the average stock price during the period in the computation and because of the net loss for the periods presented. Recent Accounting Pronouncements In August 2014, 2014 15, Disclosure of Uncertainties about an Entity s Ability to Continue as a Going Concern 2014 15” 2014 15 2014 15 December 15, 2016. 2014 15. In August 2018, 2018 13, 820 2018 13 2018 13 December 15, 2019. 3 January 1, 2020. not

Note 2 - Fair Value Measurement

Note 2 - Fair Value Measurements	3 Months Ended
	Mar. 31, 2022
Notes to Financial Statements
Fair Value Disclosures [Text Block]	2. Fair value is defined under FASB ASC 820, Fair Value Measurement and Disclosures 820 820 820 820 three first two may Level 1 not 1 valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not Level 2 one not Level 3 In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level of input that is significant to the fair value measurement. The Company’s assets and liabilities that are measured at fair value on a non-recurring basis include cash, accounts payable, accrued expenses, and interest payable given their short-term nature. Furthermore, the fair value of the Company’s notes payable are initially measured at fair value given that they are estimated based on current rates that would be available for debt of similar terms. The following tables provide information about the Company’s financial instruments measured at fair value on a recurring basis as of March 31, 2022 December 31, 2021 Balance as of March 31, Level 1 Level 2 Level 3 2022 Investments: Publicly traded common stock $ 489,140 $ - $ - $ 489,140 Publicly traded options 22,748 22,748 Private company common stock - - 178,824 178,824 Private company preferred stock - - 4,781,520 4,781,520 Total $ 511,888 $ - $ 4,960,344 $ 5,472,232 Balance as of December 31, Level 1 Level 2 Level 3 2021 Investments: Publicly traded common stock $ 575,720 $ - $ - $ 575,720 Publicly traded options 28,598 28,598 Private company common stock - - 178,824 178,824 Private company preferred stock - - 4,781,520 4,781,520 Total $ 604,318 $ - $ 4,960,344 $ 5,564,662 The following tables presents the Company’s investments measured at fair value using significant unobservable inputs (Level 3 Fair Value as of March 31, 2022 Valuation Technique Unobservable Inputs Private Company Common Stock $ 178,824 Purchase price 3-10-2021 Acquisition cost Private Company Preferred Stock $ 4,781,520 company valuation average range $1.2bn to $5.0bn, best fit $2.6bn Big data technology "MESE" system, and SPAC inqueries Fair Value as of December 31, 2021 Valuation Technique Unobservable Inputs Private Company Common Stock $ 178,824 Purchase price 3-10-2021 Acquisition cost Private Company Preferred Stock $ 4,781,520 company valuation average range $1.2bn to $5.0bn, best fit $2.6bn Big data technology "MESE" system, and SPAC inqueries The following table presents additional information about Level 3 three March 31, 2022 twelve 2021. may 3 3 may Three Months Ended March 31, 2022 Balance as of December 31, 2021 $ 4,960,344 Unrealized gain on investments - Purchase of investment - Balance as of March 31, 2022 $ 4,960,344 Twelve Months Ended December 31, 2021 Balance as of December 31, 2020 $ 2,574,665 Unrealized gain on investments 2,206,855 Purchase of investment 178,824 Balance as of December 31, 2021 $ 4,960,344

Note 3 - Investments

Note 3 - Investments	3 Months Ended
	Mar. 31, 2022
Notes to Financial Statements
Investment [Text Block]	3. TangoMe, Inc. On March 30, 2012, 2021 $2.6bn, December 31, 2021. twelve December 31, 2021. no three March 31, 2022, Buoy Health, Inc. On March 17, 2021 March 31, 2022. Arcimoto, Inc. During fiscal year 2014 1 1 2017 2017, one October 2, 2015 October 2, 2025. two one September 17, 2017, December 31, 2021 March 31, 2022 March 31, 2022 March 31, 2022.

Note 4 - Related Party Transact

Note 4 - Related Party Transactions	3 Months Ended
	Mar. 31, 2022
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	4. On December 31, 2014 one December 31, 2015 March 31, 2022 December 31, 2021 March 31, 2022 December 31, 2021 From the time period January 2016 March 2021, March 31, 2022 March 31, 2022 December 31, 2021 March 31, 2026. On March 10, 2021 March 11, 2026 March 31, 2022 December 31, 2021 March 31, 2022 December 31, 2021

Note 5 - Note Payable

Note 5 - Note Payable	3 Months Ended
	Mar. 31, 2022
Notes to Financial Statements
Long-Term Debt [Text Block]	5. On March 31, 2012, third March 31, 2017. April 1, 2017. March 31, 2022 December 31, 2021 Furthermore, the Company has a note payable agreement with a related party, William R. Hambrecht. This note carries a 7.75% interest rate per annum and had a maturity date of December 31, 2015. March 31, 2022 December 31, 2021 December 31, 2025. A loan was made to Ironstone Group by William R. Hambrecht resulting from William R. Hambrecht paying the interest on the Bank Letter of Credit. The loan from William R. Hambrecht interest rate is 7.75%. The loan balance at March 31, 2022 December 31, 2021 March 31, 2022 December 31, 2021 March 31, 2026. On March 10, 2021 March 11, 2026 March 31, 2022 December 31, 2021 March 31, 2022 December 31, 2021 The scheduled maturities of notes and LOC payable outstanding as of March 31, 2022 2025 2026 pending Total Notes payable $ - $ - $ 2,386,950 $ 2,386,950 Letter of Credit - - 348,843 348,843 Notes payable - related party 182,000 442,313 - 624,313 Total $ 182,000 $ 442,313 $ 2,735,793 $ 3,360,106

Note 6 - Line of Credit Arrange

Note 6 - Line of Credit Arrangement	3 Months Ended
	Mar. 31, 2022
Notes to Financial Statements
Line of Credit Facility [Text Block]	6. The Company has a line of credit arrangement with First Republic Bank (the “lender”) with a borrowing limit of $350,000 with interest based upon the lender’s prime rate plus 4.5% and is payable monthly. At March 31, 2022 December 31, 2021, March 31, 2022 December 31, 2021, March 31, 2022 December 31, 2021

Note 7 - Stockholders' Equity

Note 7 - Stockholders' Equity	3 Months Ended
	Mar. 31, 2022
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	7. EQUITY Common Stock On January 2, 2014, On May 1, 2014, third September 30, 2014, third Treasury Stock On September 15, 2003, December 31, 2008, March 31, 2022 December 31, 2021, Preferred Stock The Company is authorized to issue up to five million shares of preferred stock without further shareholder approval; the rights, preferences and privileges of which would be determined at the time of issuance. No shares have been issued as of March 31, 2022 December 31, 2021. Stock-Based Compensation For the quarter ended March 31, 2022 March 31, 2021. Stock Option Plans The Company is currently revising its existing Equity Incentive Plan. As of March 31, 2022, Earnings (Loss) Per Share Basic net income (loss) per share is computed by dividing the net income (loss) by the weighted number of shares of common stock outstanding during the period. Diluted net income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of common and dilutive potential common shares outstanding during the period, if dilutive. Potentially dilutive common equivalent shares are composed of the incremental common shares issuable upon the exercise of stock options. The following is the computations of the basic and diluted net income per share and the anti-dilutive common stock equivalents excluded from the computations for the periods presented: Quarters Ended March 31, 2022 March 31, 2021 Numerator: Net Operating Loss $ (145,752 ) $ (79,398 ) Denominator: Weighted average shares outstanding - basic 2,191,689 2,191,689 Effect of dilutive potential shares 345,000 170,000 Shares outstanding - diluted 2,536,689 2,361,689 Net loss per share - basic $ (0.07 ) $ (0.04 ) Net loss per share - diluted $ (0.06 ) $ (0.03 ) Quarters Ended March 31, 2022 March 31, 2021 Numerator: Net Comprehensive Earnings after income taxes $ (238,182 ) $ (79,398 ) Denominator: Weighted average shares outstanding - basic 2,191,689 2,191,689 Effect of dilutive potential shares 345,000 170,000 Shares outstanding - diluted 2,536,689 2,361,689 Net gain (loss) per share - basic $ (0.11 ) $ (0.04 ) Net gain (loss) per share - diluted $ (0.09 ) $ (0.03 )

Note 8 - Management's Plans

Note 8 - Management's Plans	3 Months Ended
	Mar. 31, 2022
Notes to Financial Statements
Substantial Doubt about Going Concern [Text Block]	8. S PLANS As reflected in the accompanying financial statements, the Company has net losses and has a negative cash flow from operations. The attainment of profitable operations is dependent upon future events, including liquidity events in privately held investments in excess of purchase price, and or the profitable sale of publicly traded investments. If necessary, to provide liquidity, the Company may may may not

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of Ironstone Group, Inc. and its subsidiaries, AcadiEnergy, Inc., Belt Perry Associates, Inc., DeMoss Corporation, and TaxNet, Inc. (collectively the “Company”). All significant intercompany accounts and transactions have been eliminated in consolidation.
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The unaudited condensed consolidated financial statements included herein have been prepared by the Company in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures, normally included in financial statements prepared in accordance with U.S. GAAP, have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, these unaudited condensed consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary to present fairly the financial position of the Company as of March 31, 2022 December 31, 2021, three March 31, 2022 March 31, 2021 three March 31, 2022 March 31, 2021. not may not not There have been no 10 December 31, 2021.
Going Concern [Policy Text Block]	Going Concern These financial statements contemplate the realization of assets and the satisfaction of liabilities in the normal course of business. Ironstone Group has incurred losses and negative cash flows from operations over the last ten not
Investment, Policy [Policy Text Block]	Marketable and Non-Marketable Securities Marketable and non-marketable securities have been classified by management as available for sale in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 320, March 31, 2022 December 31, 2021 not not Securities determined to be non-marketable by the Company do not that it deems most relevant. Among the factors considered by the Company in determining the fair value of financial instruments are discounted anticipated cash flows, the cost, terms and liquidity of the instrument, the financial condition, operating results and credit ratings of the issuer or underlying company, the quoted market price of publicly traded securities with similar duration and yield, the Black-Scholes Options Valuation methodology adjusted for active market, the share price of recent round of financings by an outsider, and other considerations on a case-by-case basis and other factors generally pertinent to the valuation of financial instruments.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates made in the financial statements relate to the valuation of the Company’s non-marketable investments. Actual results could differ from those estimates.
Income Tax, Policy [Policy Text Block]	Income Taxes Ironstone follows the authoritative guidance on accounting for and disclosure of uncertainty in tax positions, which requires the Company to determine whether a tax position of Ironstone is more likely than not not 50% no The Company files tax returns as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examination by federal, state, local, and foreign jurisdictions, where applicable. As of March 31, 2022, 2018 2017
Share-Based Payment Arrangement [Policy Text Block]	Stock-Based Compensation Ironstone recognizes the fair value of stock options granted on a straight-line basis over the requisite service period of the option grant, which is the standard vesting term of three The full impact of stock-based compensation in the future is dependent upon, among other things, the total number of stock options granted, the fair value of the stock options at the time of grant and the tax benefit that Ironstone may may not as assumptions regarding a number of highly complex and subjective variables. These variables include but are not
Earnings Per Share, Policy [Policy Text Block]	Basic and Diluted Loss per Share Basic loss per share (“EPS”) excludes dilution and is computed by dividing net income (loss) applicable to common shareholders by the weighted average number of common shares actually outstanding during the period. Diluted EPS reflects the dilution from potentially dilutive securities, except where inclusion of such potentially dilutive securities would have an anti-dilutive effect, using the average stock price during the period in the computation and because of the net loss for the periods presented.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements In August 2014, 2014 15, Disclosure of Uncertainties about an Entity s Ability to Continue as a Going Concern 2014 15” 2014 15 2014 15 December 15, 2016. 2014 15. In August 2018, 2018 13, 820 2018 13 2018 13 December 15, 2019. 3 January 1, 2020. not

Note 2 - Fair Value Measureme_2

Note 2 - Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2022
Notes Tables
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Balance as of March 31, Level 1 Level 2 Level 3 2022 Investments: Publicly traded common stock $ 489,140 $ - $ - $ 489,140 Publicly traded options 22,748 22,748 Private company common stock - - 178,824 178,824 Private company preferred stock - - 4,781,520 4,781,520 Total $ 511,888 $ - $ 4,960,344 $ 5,472,232 Balance as of December 31, Level 1 Level 2 Level 3 2021 Investments: Publicly traded common stock $ 575,720 $ - $ - $ 575,720 Publicly traded options 28,598 28,598 Private company common stock - - 178,824 178,824 Private company preferred stock - - 4,781,520 4,781,520 Total $ 604,318 $ - $ 4,960,344 $ 5,564,662
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]	Fair Value as of March 31, 2022 Valuation Technique Unobservable Inputs Private Company Common Stock $ 178,824 Purchase price 3-10-2021 Acquisition cost Private Company Preferred Stock $ 4,781,520 company valuation average range $1.2bn to $5.0bn, best fit $2.6bn Big data technology "MESE" system, and SPAC inqueries Fair Value as of December 31, 2021 Valuation Technique Unobservable Inputs Private Company Common Stock $ 178,824 Purchase price 3-10-2021 Acquisition cost Private Company Preferred Stock $ 4,781,520 company valuation average range $1.2bn to $5.0bn, best fit $2.6bn Big data technology "MESE" system, and SPAC inqueries
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Three Months Ended March 31, 2022 Balance as of December 31, 2021 $ 4,960,344 Unrealized gain on investments - Purchase of investment - Balance as of March 31, 2022 $ 4,960,344 Twelve Months Ended December 31, 2021 Balance as of December 31, 2020 $ 2,574,665 Unrealized gain on investments 2,206,855 Purchase of investment 178,824 Balance as of December 31, 2021 $ 4,960,344

Note 5 - Note Payable (Tables)

Note 5 - Note Payable (Tables)	3 Months Ended
	Mar. 31, 2022
Notes Tables
Schedule of Maturities of Long-Term Debt [Table Text Block]	2025 2026 pending Total Notes payable $ - $ - $ 2,386,950 $ 2,386,950 Letter of Credit - - 348,843 348,843 Notes payable - related party 182,000 442,313 - 624,313 Total $ 182,000 $ 442,313 $ 2,735,793 $ 3,360,106

Note 7 - Stockholders' Equity (

Note 7 - Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2022
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Quarters Ended March 31, 2022 March 31, 2021 Numerator: Net Operating Loss $ (145,752 ) $ (79,398 ) Denominator: Weighted average shares outstanding - basic 2,191,689 2,191,689 Effect of dilutive potential shares 345,000 170,000 Shares outstanding - diluted 2,536,689 2,361,689 Net loss per share - basic $ (0.07 ) $ (0.04 ) Net loss per share - diluted $ (0.06 ) $ (0.03 )
Schedule of Comprehensive Earnings Per Share, Basic and Diluted [Table Text Block]	Quarters Ended March 31, 2022 March 31, 2021 Numerator: Net Comprehensive Earnings after income taxes $ (238,182 ) $ (79,398 ) Denominator: Weighted average shares outstanding - basic 2,191,689 2,191,689 Effect of dilutive potential shares 345,000 170,000 Shares outstanding - diluted 2,536,689 2,361,689 Net gain (loss) per share - basic $ (0.11 ) $ (0.04 ) Net gain (loss) per share - diluted $ (0.09 ) $ (0.03 )

Note 1 - Business and Summary_2

Note 1 - Business and Summary of Significant Accounting Policies (Details Textual)	3 Months Ended
	Mar. 31, 2022
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)	3 years
Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]
Open Tax Year	2018 2019 2020 2021
State and Local Jurisdiction [Member] | California Franchise Tax Board [Member]
Open Tax Year	2017 2018 2019 2020 2021

Note 2 - Fair Value Measureme_3

Note 2 - Fair Value Measurements - Financial Instruments Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Recurring [Member] - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Investments, fair value	$ 5,472,232	$ 5,564,662
Publicly Traded Common Stock [Member]
Investments, fair value	489,140	575,720
Publicly Traded Options [Member]
Investments, fair value	22,748	28,598
Private Company Common Stock [Member]
Investments, fair value	178,824	178,824
Private Company Preferred Stock [Member]
Investments, fair value	4,781,520	4,781,520
Fair Value, Inputs, Level 1 [Member]
Investments, fair value	511,888	604,318
Fair Value, Inputs, Level 1 [Member] | Publicly Traded Common Stock [Member]
Investments, fair value	489,140	575,720
Fair Value, Inputs, Level 1 [Member] | Publicly Traded Options [Member]
Investments, fair value	22,748	28,598
Fair Value, Inputs, Level 3 [Member]
Investments, fair value	4,960,344	4,960,344
Fair Value, Inputs, Level 3 [Member] | Private Company Common Stock [Member]
Investments, fair value	178,824	178,824
Fair Value, Inputs, Level 3 [Member] | Private Company Preferred Stock [Member]
Investments, fair value	$ 4,781,520	$ 4,781,520

Note 2 - Fair Value Measureme_4

Note 2 - Fair Value Measurements - Investments Measured at Fair Value Using Significant Unobservable Inputs (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Private Company Common Stock [Member] | Valuation, Cost Approach [Member] | Purchase Price [Member]
Investments, fair value	$ 178,824	$ 178,824
Private Company Preferred Stock [Member] | Valuation, Market Approach [Member] | Measurement Input, Quoted Price [Member]
Investments, fair value	$ 4,781,520	$ 4,781,520

Note 2 - Fair Value Measureme_5

Note 2 - Fair Value Measurements - Additional Information about Level 3 Assets Measured at Fair Value on a Recurring Basis (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Balance as of December 31, 2021	$ 4,960,344	$ 2,574,665
Unrealized gain on investments	0	2,206,855
Purchase of investment	0	178,824
Balance as of March 31, 2022	$ 4,960,344	$ 4,960,344

Note 3 - Investments (Details T

Note 3 - Investments (Details Textual)	Mar. 17, 2021$ / sharesshares	Oct. 02, 2015$ / sharesshares	Mar. 30, 2012USD ($)$ / sharesshares	Mar. 31, 2022USD ($)$ / shares	Dec. 31, 2021USD ($)$ / shares	Dec. 31, 2018$ / sharesshares	Dec. 31, 2017shares	Dec. 31, 2014USD ($)shares	Sep. 30, 2021USD ($)
Arcimoto, Inc. [Member]
Share Price (in dollars per share) | $ / shares				$ 6.11	$ 7.78
Arcimoto, Inc. [Member] | Reverse Stock Split [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio							2
TangoMe, Inc, Series A Preferred Stock [Member]
Investment Owned, at Fair Value				$ 4,781,521	$ 4,781,521
Unrealized Gain (Loss) on Investments, Total					2,206,856
TangoMe, Inc, Series A Preferred Stock [Member] | Chief Executive Officer [Member]
Investment Purchased, Shares (in shares) | shares			468,121
Investment Purchased, Price Per Share (in dollars per share) | $ / shares			$ 2.14
Investment Purchased, Value			$ 1,000,000
Common Shares of Buoy Health, Inc [Member]
Investment Purchased, Shares (in shares) | shares	11,233
Investment Purchased, Price Per Share (in dollars per share) | $ / shares	$ 15.92
Investment Owned, at Fair Value									$ 178,824
Arcimoto, Inc. Series A-1 Preferred Stock [Member]
Investment Purchased, Shares (in shares) | shares								37,000
Payments to Acquire Investments, Total								$ 100,011
Options in Arcimoto, Inc [Member]
Investment Owned, at Fair Value				22,748	28,598
Unrealized Gain (Loss) on Investments, Total				5,850
Investment Owned, Balance, Shares (in shares) | shares		2,500				5,000	74,000
Option Indexed to Issuer's Equity, Strike Price (in dollars per share) | $ / shares		$ 4.121				$ 2.0605
Common Stock in Arcimoto, Inc [Member]
Investment Owned, at Fair Value				489,140	$ 575,720
Unrealized Gain (Loss) on Investments, Total				$ 86,580

Note 4 - Related Party Transa_2

Note 4 - Related Party Transactions (Details Textual) - Chief Executive Officer [Member] - USD ($)	Mar. 31, 2022	Dec. 31, 2021	Mar. 10, 2021	Dec. 31, 2014
Notes Payable, Related Party [Member]
Debt Instrument, Face Amount				$ 182,000
Debt Instrument, Interest Rate, Stated Percentage	7.75%			7.75%
Long-term Debt, Gross	$ 182,000	$ 182,000
Interest Payable	$ 126,438	122,960
Loan Payable for Interest on Letter of Credit [Member]
Debt Instrument, Interest Rate, Stated Percentage	7.75%
Long-term Debt, Gross	$ 142,313	142,313
Interest Payable	47,854	44,266
Loans Payable [Member]
Debt Instrument, Face Amount			$ 300,000
Debt Instrument, Interest Rate, Stated Percentage			6.00%
Long-term Debt, Gross	300,000	300,000
Interest Payable	$ 19,351	$ 14,680

Note 5 - Note Payable (Details

Note 5 - Note Payable (Details Textual) - USD ($)	Mar. 31, 2012	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Mar. 10, 2021	Apr. 01, 2017	Dec. 31, 2014
Proceeds from Notes Payable, Total		$ 0	$ 306,688
Notes Payable, Other Payables [Member]
Proceeds from Notes Payable, Total	$ 1,000,000
Debt Instrument, Interest Rate, Stated Percentage	8.00%					10.00%
Debt Instrument, Interest Rate, Default Percentage	10.00%
Long-term Debt, Gross		$ 2,386,950		$ 2,329,510
Notes Payable, Related Party [Member] | Chief Executive Officer [Member]
Debt Instrument, Interest Rate, Stated Percentage		7.75%					7.75%
Long-term Debt, Gross		$ 182,000		182,000
Interest Payable		$ 126,438		122,960
Debt Instrument, Face Amount							$ 182,000
Loan Payable for Interest on Letter of Credit [Member] | Chief Executive Officer [Member]
Debt Instrument, Interest Rate, Stated Percentage		7.75%
Long-term Debt, Gross		$ 142,313		142,313
Interest Payable		47,854		44,266
Loans Payable [Member] | Chief Executive Officer [Member]
Debt Instrument, Interest Rate, Stated Percentage					6.00%
Long-term Debt, Gross		300,000		300,000
Interest Payable		$ 19,351		$ 14,680
Debt Instrument, Face Amount					$ 300,000

Note 5 - Note Payable - Schedul

Note 5 - Note Payable - Scheduled Maturities (Details)	Mar. 31, 2022USD ($)
2025	$ 182,000
2026	442,313
pending	2,735,793
Total	3,360,106
Letter of Credit [Member]
2025	0
2026	0
pending	348,843
Total	348,843
Notes Payable, Other Payables [Member]
2025	0
2026	0
pending	2,386,950
Total	2,386,950
Notes Payable, Related Party [Member]
2025	182,000
2026	442,313
pending	0
Total	$ 624,313

Note 6 - Line of Credit Arran_2

Note 6 - Line of Credit Arrangement (Details Textual) - USD ($)	3 Months Ended		12 Months Ended	15 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Mar. 31, 2022
Long-term Line of Credit, Total	$ 348,843		$ 348,843	$ 348,843
Interest Expense, Debt, Total	64,106	$ 61,637
First Republic Bank [Member] | Line of Credit [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 350,000			$ 350,000
Debt Instrument, Interest Rate, Effective Percentage	7.75%			7.75%
Long-term Line of Credit, Total	$ 348,843		348,843	$ 348,843
Interest Expense, Debt, Total	$ 6,666		$ 6,843
Debt Instrument, Interest Rate, Stated Percentage			7.75%
First Republic Bank [Member] | Line of Credit [Member] | Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate				4.50%

Note 7 - Stockholders' Equity_2

Note 7 - Stockholders' Equity (Details Textual) - USD ($)	Sep. 30, 2014	May 01, 2014	Jan. 02, 2014	Sep. 15, 2003	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2008	Dec. 31, 2021
Stock Issued During Period, Shares, Warrant Exercises (in shares)	187,296	187,296
Treasury Stock, Shares, Acquired (in shares)				745,536
Treasury Stock Acquired, Average Cost Per Share (in dollars per share)				$ 0.70
Treasury Stock, Value, Acquired, Cost Method				$ 521,875			$ 699
Treasury Stock, Acquired, Percentage Outstanding Shares				50.11%
Preferred Stock, Shares Authorized (in shares)					5,000,000			5,000,000
Preferred Stock, Shares Issued, Total (in shares)					0			0
Share-Based Payment Arrangement, Expense					$ 60,857	$ 0
Share-Based Payment Arrangement, Option [Member]
Share-Based Payment Arrangement, Expense					$ 60,857	$ 0
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)					345,000
Purchase Agreement [Member]
Stock Issued During Period, Shares, New Issues (in shares)			131,429
Stock Issued During Period, Percentage Outstanding			7.00%
Stock Issued During Period, Value, New Issues			$ 230,000

Note 7 - Stockholders' Equity -

Note 7 - Stockholders' Equity - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Net Operating Loss	$ (145,752)	$ (79,398)
Shares outstanding (in shares)	2,191,689	2,191,689
Effect of dilutive potential shares (in shares)	345,000	170,000
Shares outstanding - diluted (in shares)	2,536,689	2,361,689
Net loss per share - basic (in dollars per share)	$ (0.07)	$ (0.04)
Net loss per share - diluted (in dollars per share)	$ (0.06)	$ (0.03)

Note 7 - Stockholders' Equity_3

Note 7 - Stockholders' Equity - Computation of Comprehensive Earnings (Loss) Per Share (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Net Comprehensive Earnings after income taxes	$ (238,182)	$ (79,398)
Shares outstanding (in shares)	2,191,689	2,191,689
Effect of dilutive potential shares (in shares)	345,000	170,000
Shares outstanding - diluted (in shares)	2,536,689	2,361,689
Net gain (loss) per share - basic (in dollars per share)	$ (0.11)	$ (0.04)
Net gain (loss) per share - diluted (in dollars per share)	$ (0.09)	$ (0.03)